The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure: Position paper from the Cardiorenal Working Groups of the Spanish Society of Nephrology and the Spanish Society of Cardiology

Despite the high prevalence of chronic kidney disease (CKD) and its high cardiovascular risk, patients with CKD, especially those with advanced CKD (stages 4–5 and patients on kidney replacement therapy), are excluded from most cardiovascular clinical trials. It is particularly relevant in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz, Alberto, Navarro-González, Juan F, Núñez, Julio, de la Espriella, Rafael, Cobo, Marta, Santamaría, Rafael, de Sequera, Patricia, Díez, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050562/
https://www.ncbi.nlm.nih.gov/pubmed/35498889
http://dx.doi.org/10.1093/ckj/sfab290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050562/
https://www.ncbi.nlm.nih.gov/pubmed/35498889
http://dx.doi.org/10.1093/ckj/sfab290

Ejemplares similares